Dalip J S Sirinathsinghji

Title: Dalip J S Sirinathsinghji: Innovator in Transgenic Research

Introduction

Dalip J S Sirinathsinghji is a notable inventor based in Harlow, GB. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic models for studying human diseases.

Latest Patents

Sirinathsinghji holds a patent for a transgenic mouse that expresses a familial form of human amyloid precursor protein. This innovative model includes transgenic non-human mammals that express a nucleic acid construct comprising a DNA sequence encoding a human amyloid precursor protein FAD variant. Specifically, at amino acid position 717, valine is substituted by isoleucine. These transgenic mice serve as assay systems for determining compounds that can effectively modulate the production of human amyloid precursor protein in the brain and isolated neuronal cells. The mice are shown to produce the APP-FAD variant in their brains, as demonstrated by mRNA and protein assays.

Career Highlights

Dalip J S Sirinathsinghji is currently employed at Merck & Company, Inc., where he continues to advance research in the field of transgenic technology. His work has implications for understanding and potentially treating neurodegenerative diseases.

Collaborations

Sirinathsinghji has collaborated with notable colleagues, including Gurparlash Singh and Howard Y Chen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Dalip J S Sirinathsinghji's work in transgenic research exemplifies the intersection of biotechnology and medical science. His contributions are paving the way for advancements in understanding human diseases and developing therapeutic strategies.